home / stock / bbi / bbi news


BBI News and Press, Brickell Biotech Inc. From 05/17/22

Stock Information

Company Name: Brickell Biotech Inc.
Stock Symbol: BBI
Market: NYSE

Menu

BBI BBI Quote BBI Short BBI News BBI Articles BBI Message Board
Get BBI Alerts

News, Short Squeeze, Breakout and More Instantly...

BBI - Healthcare Breakthroughs: IDRA, NMLSF, LMLLF, BBI; Life Sciences Leaders Report Latest Advances in Novel Therapeutics for Autism, Oncology, Autoimmune Diseases, and Glaucoma

NEW YORK, May 17, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Brickell Biotech (NASDAQ: BBI), Idera Pharmaceuticals (...

BBI - Brickell Biotech, Inc.'s (BBI) CEO Robert Brown on Q1 2022 Results - Earnings Call Transcript

Brickell Biotech, Inc. (BBI) Q1 2022 Earnings Conference Call May 12, 2022, 04:30 PM ET Company Participants Garth Russell - IR, LifeSci Advisors Robert Brown - Chief Executive Officer Andrew Sklawer - Co-Founder and Chief Operating Officer Albert Marchio II - Chief Financial Officer Monica L...

BBI - Brickell Biotech, Inc. 2022 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Brickell Biotech, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Brickell Biotech, Inc. 2022 Q1 - Results - Earnings Call Presentation

BBI - Brickell Biotech GAAP EPS of -$0.08 misses by $0.02, revenue of $0.09M misses by $0.05M

Brickell Biotech press release (NASDAQ:BBI): Q1 GAAP EPS of -$0.08 misses by $0.02. Revenue of $0.09M (+350.0% Y/Y) misses by $0.05M. The Company reported cash and cash equivalents of $17.3 million as of March 31, 2022, compared to $26.9 million as of December 31, 2021. Th...

BBI - Brickell Biotech Reports First Quarter 2022 Financial Results and Provides Corporate Update

Completed sale of sofpironium bromide to Botanix Pharmaceuticals for up to $9 million in upfront and potential near-term regulatory milestone payments, $168 million in potential future regulatory and sales milestone payments, plus tiered earnout payments on net sales Sale reflec...

BBI - Notable earnings after Thursday's close

AAIC, ACB, ACHV, AFRM, AGRO, AGRX, APDN, APTX, AQN, AVPT, AXU, BANX, BBI, BEAT, BIOL, BLBD, BLND, BOXL, BSQR, CBAY, CDXC, CLLS, CLVR, CODX, COMP, CORZ, CRMD, CTIC, CURI, CWCO, DARE, DUOL, EDR, ETON, EYEN, FIGS, GPL, GWH, HLI, HTGM, IBIO, IDN, OTCQB:IGXT, IMMR, INDI, INTZ, INUV, JOBY, KMPH, LC...

BBI - 3 Strategies You Need to Know For Buying Penny Stocks

Buying Penny Stocks in May? Here’s What You Need to Know If you’re looking at buying penny stocks this month, there are a lot of nuances for investors to consider. This includes factors such as inflation, rising interest rates, conflict in Ukraine, and much more. And as a ...

BBI - Brickell Biotech to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12, 2022

BOULDER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics ...

BBI - BioMed Momentum: NMLSF, BBI, LMLLF, VERU; Life Sciences Leaders Report Latest Advances in New Drug Development for Autism, COVID-19, Oncology, and Glaucoma

NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Veru Inc. (NASDAQ: VERU), PharmaDrug (OTC: LMLLF) (CSE:...

BBI - Top Penny Stocks to Buy Today? Must-Knows For Trading on May 4th

What You Need to Know About Buying Penny Stocks Today With another day of trading penny stocks and blue chips here, there is a lot that investors need to keep track of. In the past week or two, we’ve seen mostly bearish trading patterns. This is the result of overwhelming volatil...

Previous 10 Next 10